Artificial intelligence is opening a new chapter for clinical research in France — one that enables the shift to true industrial scale. By unlocking vast volumes of health data previously out of reach, AI is paving the way for real-time, large-scale studies that are both robust and inclusive, reaching broader and more diverse populations.
In their guest column published in L’Opinion, Lifen and Extens call for a collective commitment to ensure France remains a global leader in scientific and patient-focused innovation.
The op-ed is co-authored by Arnaud Houette, Founding Partner at Extens, and Franck Le Ouay, CEO of Lifen.
Read the full article here:
https://www.lopinion.fr/l-opinion-business/la-recherche-clinique-a-laube-de-sa-revolution-industrielle-grace-a-lia-par-arnaud-houette-et-franck-le-ouay